P144 - Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial
| Autor: | Necchi, A., Bajorin, D.F., Tomita, Y., Ye, D., Agerbaek, M., Enting, D., Peer, A., Milowsky, M., Kobayashi, K., Grimm, M-O., Stenner, F., David, J.M., Li, J., Chasalow, S.D., Nasroulah, F., Apfel, A., Ünsal-Kaçmaz, K., Galsky, M.D. |
|---|---|
| Zdroj: | In European Urology Open Science November 2022 45 Supplement 2:S239-S240 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|